| Entry |
|
|---|
| Name |
Glycol salicylate (JAN);
Ethylene glycol salicylate;
Norgesic (TN);
Phlogont (TN) |
|---|
| Formula |
C9H10O4
|
|---|
| Exact mass |
182.0579
|
|---|
| Mol weight |
182.17
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01909 Anti-inflammatory drug, salicylic acid derivatives
|
|---|
| Efficacy |
Analgesic, Anti-inflammatory, COX inhibitor |
|---|
| Comment |
Salicylic acid derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Classification of Japanese OTC drugs [BR:br08313]
Agents for integumentary system
57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
D01557 Glycol salicylate (JAN)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
Glycol salicylate
D01557 Glycol salicylate (JAN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01909 Anti-inflammatory drug, salicylic acid derivatives
D01557 Glycol salicylate
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS1 (COX1)
D01557 Glycol salicylate (JAN)
PTGS2 (COX2)
D01557 Glycol salicylate (JAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 13
1 C8y C 29.5221 -15.2210
2 C8y C 30.7455 -15.9193
3 C8x C 28.3177 -15.9193
4 C7a C 29.5156 -13.8310
5 C8x C 30.7455 -17.3285
6 O1a O 31.9499 -15.2210
7 C8x C 28.3177 -17.3285
8 O7a O 30.7262 -13.1327
9 O6a O 28.3049 -13.1391
10 C8x C 29.5221 -18.0396
11 C1b C 31.9363 -13.8322
12 C1b C 33.1469 -13.1339
13 O1a O 34.3570 -13.8331
BOND 13
1 1 4 1
2 2 5 2
3 2 6 1
4 3 7 1
5 4 8 1
6 4 9 2
7 5 10 1
8 7 10 2
9 8 11 1
10 1 2 1
11 11 12 1
12 1 3 2
13 12 13 1
|
|---|
